MG
STIM icon

Michael Gelband’s Neuronetics STIM Stock Holding History

Michael Gelband’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,203
Closed -$20.6K – 2041
2026
Q1 		$20.6K Sell
14,203
-58,181
-80% -$92.2K ﹤0.01% 1474
2025
Q4 		$99.9K Hold
72,384
– – ﹤0.01% 1438
2025
Q3 		$198K Buy
+72,384
New +$257K ﹤0.01% 1389
2025
Q2 		– Sell
-14,603
Closed -$54K – 1949
2025
Q1 		$54K Buy
+14,603
New +$53.3K ﹤0.01% 1367
2021
Q2 		– Sell
-58,263
Closed -$721K – 2782
2021
Q1 		$721K Buy
58,263
+28,675
+97% +$440K 0.01% 1121
2020
Q4 		$329K Buy
+29,588
New +$222K ﹤0.01% 1494

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Michael Gelband's STIM Position: Q2 2026 in Review

Michael Gelband sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 14,203 shares — an estimated $20.6K sold.

Michael Gelband first reported a position in STIM in Q4 2020 and held it in 6 quarters. The position peaked at $721K in Q1 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Michael Gelband reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 14,203 Neuronetics shares in Q2 2026, an estimated $20.6K.
  • Michael Gelband first reported a position in Neuronetics in Q4 2020 and held it in 6 quarters.
  • Michael Gelband's Neuronetics position peaked at $721K in Q1 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.